BRENDA - Enzyme Database show
show all sequences of 3.1.1.84

Crystal structure of a bacterial cocaine esterase

Larsen, N.A.; Turner, J.M.; Stevens, J.; Rosser, S.J.; Basran, A.; Lerner, R.A.; Bruce, N.C.; Wilson, I.A.; Nat. Struct. Biol. 9, 17-21 (2002)

Data extracted from this reference:

Application
Application
Commentary
Organism
medicine
because of the high catalytic proficiency of cocE, it is an attractive candidate for novel protein-based therapies for cocaine overdose
Rhodococcus sp.
Crystallization (Commentary)
Crystallization
Organism
te crystal structure of cocE, solved by multiple anomalous dispersion methods, reveals that cocE is a serine esterase composed of three domains: (1.) a canonical alpha/beta hydrolase fold (2.) an alpha-helical domain that caps the active site and (3.) a jelly-roll-like beta-domain that interacts extensively with the other two domains. The active site is identified within the interface of all three domains by analysis of the crystal structures of transition state analog adduct and product complexes, which are refined at 1.58 A and 1.63 A resolution, respectively
Rhodococcus sp.
Organism
Organism
Primary Accession No. (UniProt)
Commentary
Textmining
Rhodococcus sp.
Q9L9D7
-
-
Application (protein specific)
Application
Commentary
Organism
medicine
because of the high catalytic proficiency of cocE, it is an attractive candidate for novel protein-based therapies for cocaine overdose
Rhodococcus sp.
Crystallization (Commentary) (protein specific)
Crystallization
Organism
te crystal structure of cocE, solved by multiple anomalous dispersion methods, reveals that cocE is a serine esterase composed of three domains: (1.) a canonical alpha/beta hydrolase fold (2.) an alpha-helical domain that caps the active site and (3.) a jelly-roll-like beta-domain that interacts extensively with the other two domains. The active site is identified within the interface of all three domains by analysis of the crystal structures of transition state analog adduct and product complexes, which are refined at 1.58 A and 1.63 A resolution, respectively
Rhodococcus sp.
Other publictions for EC 3.1.1.84
No.
1st author
Pub Med
title
organims
journal
volume
pages
year
Activating Compound
Application
Cloned(Commentary)
Crystallization (Commentary)
Engineering
General Stability
Inhibitors
KM Value [mM]
Localization
Metals/Ions
Molecular Weight [Da]
Natural Substrates/ Products (Substrates)
Organic Solvent Stability
Organism
Oxidation Stability
Posttranslational Modification
Purification (Commentary)
Reaction
Renatured (Commentary)
Source Tissue
Specific Activity [micromol/min/mg]
Storage Stability
Substrates and Products (Substrate)
Subunits
Temperature Optimum [C]
Temperature Range [C]
Temperature Stability [C]
Turnover Number [1/s]
pH Optimum
pH Range
pH Stability
Cofactor
Ki Value [mM]
pI Value
IC50 Value
Activating Compound (protein specific)
Application (protein specific)
Cloned(Commentary) (protein specific)
Cofactor (protein specific)
Crystallization (Commentary) (protein specific)
Engineering (protein specific)
General Stability (protein specific)
IC50 Value (protein specific)
Inhibitors (protein specific)
Ki Value [mM] (protein specific)
KM Value [mM] (protein specific)
Localization (protein specific)
Metals/Ions (protein specific)
Molecular Weight [Da] (protein specific)
Natural Substrates/ Products (Substrates) (protein specific)
Organic Solvent Stability (protein specific)
Oxidation Stability (protein specific)
Posttranslational Modification (protein specific)
Purification (Commentary) (protein specific)
Renatured (Commentary) (protein specific)
Source Tissue (protein specific)
Specific Activity [micromol/min/mg] (protein specific)
Storage Stability (protein specific)
Substrates and Products (Substrate) (protein specific)
Subunits (protein specific)
Temperature Optimum [C] (protein specific)
Temperature Range [C] (protein specific)
Temperature Stability [C] (protein specific)
Turnover Number [1/s] (protein specific)
pH Optimum (protein specific)
pH Range (protein specific)
pH Stability (protein specific)
pI Value (protein specific)
Expression
General Information
General Information (protein specific)
Expression (protein specific)
KCat/KM [mM/s]
KCat/KM [mM/s] (protein specific)
750291
Kim
Kinetic characterization of c ...
Homo sapiens
Chem. Biol. Interact.
293
107-114
2018
-
-
1
-
-
-
1
3
-
-
-
3
-
1
-
-
-
-
-
-
-
-
5
-
1
-
-
3
1
-
-
-
1
-
-
-
-
1
-
-
-
-
-
1
1
3
-
-
-
3
-
-
-
-
-
-
-
-
5
-
1
-
-
3
1
-
-
-
-
1
1
-
3
3
728856
Fang
Rational design, preparation, ...
Rhodococcus sp., Rhodococcus sp. MB1 Bresler
ACS Chem. Biol.
9
1764-1772
2014
-
-
1
1
3
-
-
3
-
-
-
2
-
3
-
-
1
-
-
-
-
-
2
1
-
-
-
3
-
-
-
-
-
-
-
-
-
1
-
1
3
-
-
-
-
3
-
-
-
2
-
-
-
1
-
-
-
-
2
1
-
-
-
3
-
-
-
-
-
-
-
-
3
3
730250
Brim
The fate of bacterial cocaine ...
Rhodococcus sp.
J. Pharmacol. Exp. Ther.
340
83-95
2012
-
-
1
-
-
-
-
-
-
-
1
1
-
4
-
-
1
-
-
-
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
1
-
-
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
730421
Lee
Cell permeable cocaine esteras ...
Rhodococcus sp., Rhodococcus sp. MB1
Mol. Pharm.
9
1361-1373
2012
-
-
1
-
5
-
-
6
-
-
1
2
-
6
-
-
1
-
-
-
-
-
2
1
-
-
1
6
-
-
-
-
-
-
-
-
-
1
-
-
5
-
-
-
-
6
-
-
1
2
-
-
-
1
-
-
-
-
2
1
-
-
1
6
-
-
-
-
-
-
-
-
6
6
716278
Xue
Design, preparation, and chara ...
Homo sapiens
Mol. Pharmacol.
79
290-297
2011
-
-
1
-
3
-
-
4
-
-
-
-
-
1
-
-
1
-
-
1
-
-
1
-
-
-
-
4
-
-
-
-
-
-
-
-
-
1
-
-
3
-
-
-
-
4
-
-
-
-
-
-
-
1
-
1
-
-
1
-
-
-
-
4
-
-
-
-
-
-
-
-
4
4
716281
Narasimhan
Subunit stabilization and pegy ...
Rhodococcus sp.
Mol. Pharmacol.
80
1056-1065
2011
-
-
1
1
3
-
-
4
-
-
1
-
-
3
-
-
1
-
-
-
-
-
1
1
-
-
1
4
-
-
-
-
-
-
-
-
-
1
-
1
3
-
-
-
-
4
-
-
1
-
-
-
-
1
-
-
-
-
1
1
-
-
1
4
-
-
-
-
-
-
-
-
4
4
714226
Zheng
Design of high-activity mutant ...
Homo sapiens
Biochemistry
49
9113-9119
2010
-
-
1
1
10
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
1
10
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
9
9
714702
Yang
Characterization of a high-act ...
Homo sapiens
Chem. Biol. Interact.
187
148-152
2010
-
-
-
-
1
-
-
2
-
-
-
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
2
-
-
-
-
-
-
-
-
2
2
716276
Brim
A thermally stable form of bac ...
Rhodococcus sp., Rhodococcus sp. MB1
Mol. Pharmacol.
77
593-600
2010
-
1
-
1
1
-
-
4
-
-
-
-
-
7
-
-
-
-
-
-
-
-
2
-
-
-
1
-
-
-
-
-
-
-
-
-
1
-
-
1
1
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
716824
Narasimhan
Structural analysis of thermos ...
Rhodococcus sp., Rhodococcus sp. MB1
Protein Eng.
23
537-547
2010
-
1
1
-
5
-
-
4
-
-
-
-
-
6
-
-
1
-
-
-
-
-
2
-
-
-
1
5
-
-
-
-
-
-
-
-
1
1
-
-
5
-
-
-
-
4
-
-
-
-
-
-
-
1
-
-
-
-
2
-
-
-
1
5
-
-
-
-
-
-
-
-
5
5
692028
Ko
Effects of cocaine esterase fo ...
Rhodococcus sp.
Drug Alcohol Depend.
101
202-209
2009
-
1
-
-
-
-
-
-
-
-
-
-
-
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
694267
Gao
Thermostable variants of cocai ...
Rhodococcus sp.
Mol. Pharmacol.
75
318-323
2009
-
1
-
-
4
-
-
3
-
-
-
1
-
1
-
-
1
-
-
-
-
-
2
-
1
-
1
4
1
-
-
-
-
-
-
-
1
-
-
-
4
-
-
-
-
3
-
-
-
1
-
-
-
1
-
-
-
-
2
-
1
-
1
4
1
-
-
-
-
-
-
-
-
-
699760
Collins
Zhan. C.G.; Woods. J.H.: Cocai ...
Rhodococcus sp.
J. Pharmacol. Exp. Ther.
331
445-455
2009
-
1
-
-
1
-
-
-
-
-
-
-
-
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
698483
Liu
Fundamental reaction mechanism ...
Rhodococcus sp.
J. Am. Chem. Soc.
131
11964-11975
2003
-
-
-
-
-
-
-
-
-
-
-
1
-
1
-
-
-
1
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
650108
Turner
Biochemical characterization a ...
Rhodococcus sp.
Biochemistry
41
12297-12307
2002
-
1
1
1
11
-
-
10
-
-
-
1
1
2
-
-
-
-
-
-
-
-
3
-
-
-
-
9
1
1
-
-
-
-
-
-
1
1
-
1
11
-
-
-
-
10
-
-
-
1
1
-
-
-
-
-
-
-
3
-
-
-
-
9
1
1
-
-
-
-
-
-
-
-
653322
Larsen
Crystal structure of a bacteri ...
Rhodococcus sp.
Nat. Struct. Biol.
9
17-21
2002
-
1
-
1
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
695729
Bresler
Gene cloning and nucleotide se ...
Rhodococcus sp., Rhodococcus sp. MB1
Appl. Environ. Microbiol.
66
904-908
2000
-
-
1
-
-
-
-
1
-
-
2
2
-
11
-
-
1
-
-
1
1
-
6
1
1
-
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
1
-
-
2
2
-
-
-
1
-
1
1
-
6
1
1
-
-
-
1
-
-
-
-
-
-
-
-
-
171019
Pindel
Purification and cloning of a ...
Homo sapiens
J. Biol. Chem.
272
14769-14775
1997
-
-
1
-
-
-
1
4
-
-
2
1
-
1
-
1
1
-
-
1
-
-
5
1
-
-
-
-
-
-
-
-
1
1
-
-
-
1
-
-
-
-
-
1
1
4
-
-
2
1
-
-
1
1
-
1
-
-
5
1
-
-
-
-
-
-
-
1
-
-
-
-
-
-
698540
Britt
Identification of a cocaine es ...
Stenotrophomonas maltophilia, Stenotrophomonas maltophilia MB11L
J. Bacteriol.
174
2087-2094
1992
-
-
-
-
-
-
2
3
-
-
3
2
-
4
-
-
1
-
-
-
1
-
10
2
1
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
3
-
-
3
2
-
-
-
1
-
-
1
-
10
2
1
-
-
-
1
-
-
-
-
-
-
-
-
-